Why is patient’s disease impact critical to clinical trial enrollment?
- This topic has 2 replies, 2 voices, and was last updated 8 years, 3 months ago by
.
-
Posts
-
Not sure, Gavin. What do you think?
Perhaps others can chime in and help us out. Does it help you (members) to highlight certain threads?Hugs
MarionThe ECOG performance status measures the disease impact on patient’s level of functioning, daily activities and physical abilities such as walking, working, etc. It represents an important criteria for eligibility in a clinical trial and is used worldwide.
ECOG PERFORMANCE STATUS
GRADE
0 Fully active, able to carry on all pre-disease performance without restriction
1 Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work
2 Ambulatory and capable of all selfcare but unable to carry out any work activities; up and about more than 50% of waking hours
3 Capable of only limited selfcare; confined to bed or chair more than 50% of waking hours
4 Completely disabled; cannot carry on any selfcare; totally confined to bed or chair
5 Dead
- The forum ‘Clinical Trials’ is closed to new topics and replies.